The role of biologists in drug development

I’ve been diving deep into the complexities of drug development and clinical trials recently… It’s fascinating how biologists play such a crucial role in understanding molecular interactions and how they impact efficacy and safety. I’d love to hear any experiences or insights others have regarding their involvement in this field. Have you worked on any compelling projects or faced significant challenges in drug trials?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​⁠​⁠​‌​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌‍‌‍⁠‍‌‌‍‍‌​⁠⁠‌‌‍‍‌⁠​⁠‌⁠‌‌‌‍​‌​⁠‌‌‌‍‌​‌‌​​​⁠‌​​⁠‍‌‌‍‌‍‌⁠​​‌⁠‍‌​‍​‍‌⁠⁠‌​

, the complexities can be overwhelming! When I worked on a project involving targeted drug delivery, we realized that early modeling of molecular interactions really shaped our trials and improved our outcomes. It’s all about collaborating closely with chemists and clinicians to ensure we’re on the right track, especially considering how much impact efficacy and safety can vary with small adjustments.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​⁠‌‍​⁠​​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​⁠​⁠​‌​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‍​‌‍⁠⁠‌⁠‌‌‌​‍⁠‌‍‍‌‌​⁠‌‌‌‍‍‌​‌‌‌‌‍‍‌‍​‍‌​​‌‌‌​​‌‍‌‍‌​​‌‌‍‍‌‌​‍‍​‍​‍‌⁠⁠‌

I’ve seen how crucial early modeling is too! In one project, using software like BioVIA Discovery Studio helped us predict interaction outcomes, which saved time on initial trials. Have you used similar tools?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​‍‌‍‍‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌‍​⁠‍‌​⁠‌‍​⁠​​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​⁠​⁠​‌​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​⁠⁠‌​​‍‌‌​⁠​⁠‌​‌⁠‍‌‌⁠‍‍‌⁠‌⁠‌‍‌​‌⁠​‌‌‍​⁠‌​​‍‌⁠‍‍‌⁠‍‍‌‍‌‌‌​⁠⁠‌​‌‌​‍​‍‌⁠⁠‌